Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
about
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetesThe involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genesInnate immunity and intestinal microbiota in the development of Type 1 diabetesInhibition of autoimmune type 1 diabetes by gastrointestinal helminth infectionThe hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetesElevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development.Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model.Prevention of diabetes in NOD mice by repeated exposures to a contact allergen inducing a sub-clinical dermatitis.Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice.The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditionsWinner of the 2007 Society for Thermal Medicine Young Investigator Award. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice.Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.CXC chemokine ligand 10 DNA vaccination plus Complete Freund's Adjuvant reverses hyperglycemia in non-obese diabetic mice.Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.Cytokines in autoimmunity: role in induction, regulation, and treatment.Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice.Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC TransplantationTreatment with incomplete Freund's adjuvant and Listeria monocytogenes delays diabetes via an interleukin-17-secretion-independent pathwayBreakdown in peripheral tolerance in type 1 diabetes in mice and humansPrevention of diabetes in nonobese diabetic mice by dendritic cell transfer.Adjuvant immunotherapy is dependent on inducible nitric oxide synthaseTriggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes.CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transferReversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C.Genes mediating environment interactions in type 1 diabetes.Helminth infection and type 1 diabetes.Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD micePersistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant.Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury.A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant.TNF, TNF Inducers and TNFR2 Agonists: A New Path to Type 1 Diabetes Treatment.Potential route of Th17/Treg cell dynamics in targeting type 1 diabetes and rheumatoid arthritis: an autoimmune disorder perspective.BCG and protection against inflammatory and auto-immune diseases.Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?Viruses and other perinatal exposures as initiating events for beta-cell destruction.Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.
P2860
Q21134119-E829D5C8-5C3D-4FE8-A05C-178176FEF306Q21195858-C82DC09A-2E2F-4E3B-9E14-F6E11315CED5Q24647312-CD5C4EDD-F597-4DB6-BFB5-FFB73C9E6116Q24678832-E2BB8398-7216-4897-943D-3A754C8756B8Q27000404-282FEDA8-0A60-4531-BB80-CEADECBFC915Q33369569-BF4B3E32-39FA-4742-A4E4-565695696C61Q33410248-3FFC800B-DE6C-416C-B6E1-061BE1587229Q33582268-E90E55FC-66E2-4F78-BBEA-1806D93243EAQ33632219-67F479D3-4EBA-44D6-AEDB-4645E98748CDQ33833767-72BC0110-D2B7-4938-88F5-7D7CA44B5659Q33953866-F11A95A9-F180-4B2B-BA1D-7613E7267852Q34063601-B9269B87-28D7-4E8A-A41B-5B2445583D68Q34201095-B250FE8A-991C-491A-A380-CDE4ACC667B6Q34703152-C4767E4F-4E24-4907-B3DC-A2B7DE25287EQ34731064-16AA16B2-A941-4608-8EAB-04ED0A1CA8BFQ35294424-EBBA1E5F-32CB-4AB6-A331-F9B15A4DF1AEQ35573510-ADE8863B-F80D-43E6-93F9-9F7B3F0C9024Q35590808-3E653E4E-DAC9-409B-8A31-0C653C648E5BQ35603139-A80D67C9-2C5E-436A-8C86-7574008D2CE4Q35645163-160F8877-7715-4B2B-9841-91F8B08B422AQ35754074-3D1E0B54-B75D-4CFD-B1E3-7F80F141F172Q35765731-1B306AB2-D10A-4798-B054-A8CA3F40F188Q35821238-A435C7E2-2D40-432A-89E6-1D244530744CQ36369143-086DC343-3281-436F-A539-70CAEE9C6E6EQ36375231-F1AF369D-DCD4-402C-BB91-804C3D8CD1F3Q36376604-EDF20EBD-2E0A-4AFD-A090-83C03B90DF5EQ36494558-DC891E51-EC04-457E-9124-E76FDD3D28A5Q36603252-41B3B706-DF55-4708-8237-045F1072D963Q36816687-F609CDE9-CB4D-4236-AA45-3D306614500BQ37088203-AB46B1CE-4A06-44E5-A1B5-CE4957B90863Q37089400-384B2432-B5A0-4A96-855B-858128DED9D0Q37351448-CBB5C862-1E22-461F-AA00-ADB25F1890FEQ37430702-FA4C0C85-655C-427C-8641-3EFDFCC1B1B4Q37599375-97779794-128D-4107-BD1F-543FA98B9767Q38607412-EE177224-2161-4D50-9ED3-6B6E61839B91Q39027725-E7CECCF5-5377-4F19-8A8B-BC23389EC3ACQ40203403-09FCA25E-BF47-4134-8C6B-55F6BA5FA4A1Q41205365-AFDEBC49-B929-450E-874C-F2F8162EE10AQ41695561-24B71FB3-A016-4654-BA5C-73B19B224BA4Q42260307-C9BB41FA-78C1-4773-9EB6-B9A7B9517BA3
P2860
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@ast
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@en
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@nl
type
label
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@ast
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@en
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@nl
prefLabel
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@ast
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@en
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@nl
P2093
P356
P1433
P1476
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.
@en
P2093
P304
P356
10.2337/DIAB.39.5.583
P407
P577
1990-05-01T00:00:00Z